You are here: Industry Insights > rise

News List

Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia pharmaceutical-business-review
January 13, 2021
Teva Pharmaceuticals Industries and MedinCell announced positive results for study TV46000-CNS-30072 (the RISE study – The Risperidone Subcutaneous Extended-Release Study), a Phase 3 clinical trial designed to evaluate the efficacy of TV-46000/mdc-IRM ...
Aggressive Uterine Cancer on the Rise, Especially in Blacks: Study drugs
May 29, 2019
There's been a steep uptick in aggressive uterine cancers among American women, especially black women, since 2000, a new study shows.
Analysts believe M&A activity in the pharmaceutical sector could rise in 2019 firstwordpharma
January 13, 2019
Analysts and investors hinted that M&A activity among drugmakers could increase in 2019 compared to the prior year, Business Insider reported Friday. The speculation comes after Bristol-Myers Squibb agreed to purchase Celgene for $74 billion, followed by
Analysts believe M&A activity in the pharmaceutical sector could rise in 2019 firstwordpharma
January 13, 2019
Analysts and investors hinted that M&A activity among drugmakers could increase in 2019 compared to the prior year, Business Insider reported Friday. The speculation comes after Bristol-Myers Squibb agreed to purchase Celgene for $74 billion, followed by